The design of PNA, consisting of a novel combination of a HSA and nitroxide as a metal-free superoxide dismutase (SOD3) mimetic, has advantages over small molecular weight and membrane permeable nitroxide that mimics SOD1, SOD2, and SOD3, in cancer therapy. Here, SOD3 is linked to cancer.